5-Amino-1-Methylquinolinium Human Preclinical Research Overview

At a Glance: 5-Amino-1-Methylquinolinium in Preclinical Science

5-Amino-1-methylquinolinium (commonly abbreviated as 5-Amino-1MQ) is a quinolinium derivative engineered to selectively inhibit the cytosolic enzyme nicotinamide N-methyltransferase (NNMT). By blocking NNMT activity, research indicates the molecule prevents the irreversible methylation of nicotinamide (NAM) into 1-methylnicotinamide (1-MNA), thereby preserving intracellular NAM availability for salvage pathways.

In preclinical model systems, preserving the cytosolic pool of nicotinamide directly supports cellular nicotinamide adenine dinucleotide (NAD+) biosynthesis and enhances mitochondrial respiration. Laboratory investigations focus primarily on its application in high-fat diet rodent models, cellular energy expenditure assays, and skeletal muscle metabolic profiling.

Researchers evaluating 5-amino-1-methylquinolinium human cellular lines or animal models require ultra-pure, identity-verified reagents. PX1 Research provides fully characterized material accompanied by batch-specific analytical testing to ensure experimental reproducibility across in vitro and animal models.

What Is 5-Amino-1-Methylquinolinium (5-Amino-1MQ)?

5-Amino-1-methylquinolinium is a synthetic small-molecule methylquinolinium salt characterized by its specific capacity to bind the active site of NNMT. Unlike large peptide chains, 5-Amino-1MQ is a low-molecular-weight non-peptide compound with favorable membrane permeability, allowing rapid intracellular distribution in cell culture assays.

NNMT is predominantly expressed in metabolic tissues, including adipose tissue, liver parenchyma, and skeletal muscle. When NNMT is overexpressed—such as in states of metabolic strain or high-fat exposure—it consumes excess methyl groups from S-adenosylmethionine (SAM) and depletes intracellular NAM. 5-Amino-1MQ acts as a reversible, competitive inhibitor that restores homeostasis within these metabolic cascades.

Investigational protocols utilizing 5-Amino-1MQ across our catalog of research peptides and metabolic modulators seek to map the exact regulatory mechanisms governing adipocyte expansion, basal metabolic rate, and intracellular ATP production.

Mechanism of Action: NNMT Inhibition, NAD+ Pathways, and Energy Metabolism

The primary mechanism of 5-Amino-1MQ revolves around competitive inhibition of NNMT. Under non-inhibited conditions, NNMT transfers a methyl group from S-adenosylmethionine (SAM) to nicotinamide (NAM), generating 1-methylnicotinamide (1-MNA) and S-adenosylhomocysteine (SAH). Because 1-MNA is excreted or further metabolized, this reaction permanently drains the cell of NAM—the critical precursor required by nicotinamide phosphoribosyltransferase (NAMPT) to generate NAD+.

By halting this methylation sink, 5-Amino-1MQ increases intracellular levels of both NAM and NAD+. Elevating cellular NAD+ concentrations activates NAD+-dependent enzymes, specifically sirtuin 1 (SIRT1) and poly(ADP-ribose) polymerases (PARPs). SIRT1 activation subsequently deacetylates peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α), driving mitochondrial biogenesis, oxidative phosphorylation, and fatty acid beta-oxidation.

Furthermore, by conserving SAM relative to SAH, NNMT inhibition maintains favorable cellular methylation potential. In vitro data indicate that this dual action—boosting mitochondrial capacity while balancing SAM/SAH ratios—leads to reduced lipid accumulation in mature adipocytes without altering food intake parameters in animal subjects.

5-Amino-1-Methylquinolinium Human Research Context and Preclinical Literature

In academic literature, queries regarding 5-amino-1-methylquinolinium human applications frequently reference translational studies evaluating human tissue explants, cultured primary human adipocytes, and human skeletal muscle myotubes. In vitro testing on human cell lines demonstrates that NNMT expression correlates directly with insulin resistance and adipocyte hypertrophy.

When applied to cultured human subcutaneous adipocytes, 5-Amino-1MQ exposure results in a measurable decrease in intracellular triglyceride accumulation and an increase in basal oxygen consumption rates (OCR). These findings confirm that human-derived metabolic enzymes respond to 5-Amino-1MQ-mediated inhibition in a manner comparable to rodent models.

Despite significant interest generated by preclinical data, 5-Amino-1MQ remains an investigational compound reserved exclusively for laboratory research. It has not received regulatory approval for therapeutic or clinical administration in humans. Investigators sourcing the molecule from our research library use it strictly to evaluate enzyme kinetics, mitochondrial function, and adipose tissue dynamics.

Comparative Analysis: 5-Amino-1MQ vs. Complementary Metabolic Targets

To contextualize the scientific role of 5-Amino-1MQ, researchers frequently compare its targeted NNMT pathway against broader metabolic regulators such as mitochondrial peptides and AMPK activators.

While direct NAD+ precursors like Nicotinamide Mononucleotide (NMN) provide raw substrate for NAD+ production, 5-Amino-1MQ acts upstream by preventing the enzymatic degradation of the underlying NAM pool. Consequently, combination assays often examine whether combining NNMT inhibitors with mitochondrial-derived peptides yields synergistic improvements in cellular respiration.

The table below outlines how 5-Amino-1MQ compares to other prominent laboratory reagents in metabolic research:

Standard Laboratory Verification Criteria for Small-Molecule Vendors

Ensuring reproducibility in cellular and animal models requires rigorous analytical verification of small-molecule compounds. Impurities, heavy metals, or residual solvents can invalidate metabolic assays, induce cell toxicity, or alter enzymatic binding kinetics.

To meet the standards of modern academic and industrial research laboratories, PX1 Research subjects every production lot of 5-Amino-1MQ to a standardized three-tier analytical validation protocol:

1. High-Performance Liquid Chromatography (RP-HPLC): Establishes chemical purity, ensuring freedom from degradation products or synthetic intermediates with a minimum threshold of 98.0% purity. 2. Liquid Chromatography-Mass Spectrometry (LC-MS): Confirms exact molecular weight and identity matching theoretical chemical structure. 3. Endotoxin & Bioburden Testing: Assays bacterial endotoxin levels (EU/mg) via Chromogenic LAL testing to guarantee safety for sensitive cell cultures and animal models. 4. Batch Traceability & Public COAs: Every vial displays a lot number linked directly to a downloadable Certificate of Analysis verified by an independent third-party domestic testing facility.

Laboratories sourcing reagents for high-throughput screening or quantitative assay protocols can review full documentation prior to order placement.

Handling, Reconstitution, and Laboratory Storage Protocols

5-Amino-1MQ is typically supplied as a lyophilized or crystalline powder in salt form (such as iodide or bromide salt) to ensure long-term stability. Proper laboratory protocol must be followed to maintain chemical integrity during reconstitution and assay preparation.

Solubility Profile: 5-Amino-1MQ exhibits high solubility in polar organic solvents such as Dimethyl Sulfoxide (DMSO) and moderate solubility in sterile physiological saline or phosphate-buffered saline (PBS), depending on the specific salt formulation. For cell culture applications, stock solutions are commonly prepared in anhydrous DMSO and subsequently diluted into aqueous assay media, keeping final DMSO concentrations below cytotoxic thresholds (typically <0.1% v/v).

Storage Parameters: Solid powder should be stored sealed at -20°C in a desiccated environment protected from light. Reconstituted stock solutions should be aliquoted into single-use polypropylene tubes and maintained at -80°C to prevent freeze-thaw degradation. Under these conditions, stock solutions remain stable for extended analytical series.

Red Flags When Evaluating Small-Molecule and Peptide Suppliers

The market for research chemicals contains significant variability in quality control, product purity, and regulatory compliance. Principal investigators and laboratory procurement officers should remain vigilant against several common vendor red flags:

Lack of Lot-Specific COAs: Reputable vendors provide individual testing reports matching the exact lot code printed on the container, rather than generic or static 'example' certificates. Absence of third-party verification is a primary indicator of substandard sourcing.

Absence of Endotoxin Screening: In vitro cell cultures and in vivo rodent models are highly sensitive to lipopolysaccharide (LPS) contamination. Vendors selling unrefined chemical powders without bioburden data risk compromising entire experimental datasets.

Non-Compliant Medical Claims: Vendors making therapeutic, medical, or human dosing claims violate research-use guidelines and frequently lack legitimate laboratory quality standards. Compliance with strictly defined laboratory research parameters is essential.

Unclear Sourcing and Slow Domestic Fulfillment: Overseas drop-shipping or unverified overseas synthesis facilities introduce unknown contamination vectors and transit delays that can degrade temperature-sensitive reagents.

Synergistic Research Pathways: 5-Amino-1MQ and Mitochondrial Peptides

In modern preclinical literature, 5-Amino-1MQ is frequently integrated into multi-target metabolic study designs alongside mitochondrial signaling agents. Because 5-Amino-1MQ targets cytosolic NAD+ degradation pathways, researchers often pair it with mitochondrial-targeted molecules to investigate comprehensive cellular bioenergetics.

For instance, investigators exploring mitochondrial peptide signaling frequently combine 5-Amino-1MQ assays with MOTS-c, a mitochondrial-derived peptide that regulates skeletal muscle metabolic homeostasis and folate-purine interactions.

Similarly, research teams evaluating mitochondrial electron transport chain efficiency and reactive oxygen species (ROS) reduction examine 5-Amino-1MQ alongside cardiolipin-targeted peptides like SS-31. Broadening experimental frameworks across multiple metabolic nodes provides a more holistic model of cellular energy regulation. Institutional buyers can explore our full range of signaling compounds through our bulk procurement program.

Ordering 5-Amino-1MQ from PX1 Research

PX1 Research provides verified, analytical-grade 5-Amino-1MQ engineered specifically for demanding in vitro and preclinical research applications. Each lot undergoes comprehensive identity and purity testing to guarantee batch-to-batch consistency across experimental trials.

When you order 10 mg vials of 5-Amino-1MQ, your shipment is dispatched same-day for orders placed Monday through Friday before 3:00 PM EST. Packages ship directly from our climate-controlled fulfillment centers in California and Arizona via tracked domestic carriers.

Every vial features a dedicated QR code linking directly to its lot-specific Certificate of Analysis, confirming HPLC purity, mass spectrometry identity, and endotoxin thresholds. For custom assay configurations, specialized quantities, or lab procurement inquiries, our technical support team responds within one business day.